Can a combination of probiotics and nutraceuticals help preventing the abemaciclib-related diarrhea in breast cancer patients?
Minerva Gastroenterol (Torino)
.
2024 Jun;70(2):242-244.
doi: 10.23736/S2724-5985.24.03647-7.
Epub 2024 Mar 14.
Authors
Umberto Pacetti
1
,
Francesco DI Pierro
2
3
,
Massimiliano Cazzaniga
3
,
Ilaria Cavecchia
4
,
Mariarosaria Matera
5
,
Alexander Bertuccioli
6
,
Nicola Zerbinati
2
,
Luigina Guasti
2
,
Simonetta C Stani
7
Affiliations
1
Centro Oncologico Santo Spirito-Nuovo Regina Margherita, Rome, Italy - umberto.pacetti@aslroma1.it.
2
Department of Medicine and Surgery, University of Insubria, Varese, Italy.
3
Scientific Department, Velleja Research, Milan, Italy.
4
Microbiomic Department, Koelliker Hospital, Turin, Italy.
5
Department of Pediatric Emergencies, Misericordia Hospital, Grosseto, Italy.
6
Department of Biomolecular Sciences, University of Urbino Carlo Bo, Urbino, Italy.
7
Centro Oncologico Santo Spirito-Nuovo Regina Margherita, Rome, Italy.
PMID:
38483445
DOI:
10.23736/S2724-5985.24.03647-7
No abstract available
Publication types
Letter
MeSH terms
Aminopyridines* / therapeutic use
Benzimidazoles* / therapeutic use
Breast Neoplasms*
Diarrhea*
Dietary Supplements*
Female
Humans
Probiotics* / therapeutic use
Substances
Benzimidazoles
abemaciclib
Aminopyridines